Thursday 19 December 2019

Urinalysis Test Market Grow by CAGR of 5.85% From (2019 to 2025)

Market Highlights
Urinalysis Test Market is expected to register a CAGR of 5.85% during the forecast period, with a market value of USD 1568.46 Million till 2025.
Segment Analysis
The Global Urinalysis Test Market is segmented into product type, test type, application, and end-user
On the basis of product type, the urinalysis test market has been classified as consumables and instruments. The consumables segment has been further divided into pregnancy & fertility kits, dipsticks, disposables, and reagents. The instruments segment has been additionally categorized as automated urine analyzers, semi-automated urine analyzers, and point-of-care urine analyzers. The automated urine analyzers segment has been further classified as biochemical urine analyzers, sediment urine analyzers, and integrated urine analyzers. The sediment urine analyzers segment has been additionally bifurcated into microscopy analyzers and flow cytometry analyzers. The consumables segment is expected to command the market over the assessment period owing to the repetitive use of consumables during urinalysis procedures.
Regional Analysis
The Global Urinalysis Test Market has been segmented on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The European urinalysis test market has been additionally segmented into Western Europe and Eastern Europe. The Western Europe urinalysis test market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The urinalysis test market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. The urinalysis test market in the Middle East & Africa has been bifurcated into the Middle East and Africa.
The Americas was the largest market for urinalysis tests in 2018 due to the rising demand for automated urine analyzers, technological advancements in urinalysis test instruments, and rising prevalence of kidney and liver diseases in the US and Canada. In North America, the US held the largest share of the market in 2018 owing to the presence of significant players focused on manufacturing urine analyzers and consumables, rising research initiatives in the field of urinalysis, and growing awareness about personalized medicines. On the other hand, Asia-Pacific is expected to represent the highest market growth potential over the forecast period due to rapidly developing medical technology, increasing demand for urine testing products, surging geriatric population, and growing awareness about urinalysis tests in China, India, Japan, and Australia.
Market Players
MRFR recognizes the following companies as the Key Players in the Global Urinalysis Test Market— Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US), URIT Medical Electronic Ltd (China), Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc. (Japan), Sysmex Corporation (Japan), and Alere Inc. (US).
Key Findings of the Study
  • The Global Urinalysis Test Market was valued at USD 1057.01 Million in 2018, is estimated to grow at USD 1568.5 Million By 2025 at a CAGR of 5.85% during the assessment period.
  • Americas accounted for the largest share of the global market due to the presence of key market players and increasing the rising prevalence of diseases, and government support are driving the growth of the market in this region.
  • On the basis of product type, consumables accounted for the largest market share of 8% in 2018, with a market value of USD 590.15 Million.
Hottest Trending Reports
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , ,

CBD Oil (Cannabidiol Oil) Market Value Chain, Factor Analysis, Region and Forecasts To 2023

CBD oil market is predicted to touch USD 3782.32 million at a 38.45% CAGR between 2015-2023

The CBD Oil Market is estimated to be valued at USD 3782.32 Million by 2024 and expected to grow at a CAGR of 38.45% during the forecast period. CBD is a cannabinoid found in the cannabis plant. CBD oil acts as a natural pain reliever, have anti-inflammatory properties and could reduce epileptic seizures, etc.
From the past few years, the market for CBD oil had been increasing owing to rising legalization of cannabis and growing R&D in the field. Following the same, it is noted that new market players have been emerging in the market owing to the rising demand for CBD oil.
Segment Analysis
Global CBD oil market has been segmented on the basis of type, and application. On the basis of type, the market has been divided into hemp-derived and marijuana-derived types. The Hemp-derived CBD oil type is holding the major share of the overall CBD oil market. It has been estimated that the hemp-derived segment is growing at the highest CAGR to reach USD 2,092.97 Million by the end of 2024. Most of the legal CBD-based products in the market are hemp-based. According to the 2018 Farm Bill, companies can legally grow, manufacture, possess, and sell hemp-derived CBD products.  
Based on application, the global CBD oil market is segmented into pharmaceuticals, food, cosmetics, and others. Among these segments, the cosmetic industry accounts for the largest market share owing to the anti-inflammatory and non-psychoactive properties of CBD. Moreover, CBD infused beauty products are a major trend these days. For instance, Folium Biosciences, the US-based cannabinoid producer, offers cosmeceuticals which include CBD infused moisturizing relief cream.


List Of Tables:
TABLE 1 PRIMARY INTERVIEWS 16
TABLE 2 GLOBAL HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 32
TABLE 3 AMERICAS HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 33
TABLE 4 NORTH AMERICA HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 33
TABLE 5 EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 34
TABLE 6 WESTERN EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 34
TABLE 7 ASIA-PACIFIC: HEMP BASED PRODUCTS MARKET, BY COUNTRY 2015–2023 (USD MILLION) 35
TABLE 8 REST OF THE WORLD (ROW) HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 35

Read More Here !! https://www.marketwatch.com/press-release/cbd-oil-cannabidiol-oil-market-research-report-2019-industry-trend-growth-future-scope-demand-top-key-players-update-hemp-oil-demand-and-regional-forecast-2019-12-04
Posted by at 7 comments:
Labels: , , ,

Worldwide 3D printed medical Implants Market Size, Share Analysis, Strategies, Revenue and Forecasts to 2024

Market Highlights
The global 3D printed medical implants market held a market value of USD 1,124.68 million in 2018 and is projected to grow at a CAGR of 18.1% over the forecast period.   
3D printing is a procedure that uses a layer by layer method for the creation of a real or physical object from a digital design. This technology is in its early stage in healthcare applications and holds strong potential for a wide variety of applications in medical implants. Factors such as vast technological advancements in the medical device industry and strategic investments done by leading players are expected to drive the market growth. For instance, EnvisionTEC signed a partnership with Abergower as its global reseller partner to expand Envision’s global footprints in 3D printed medical devices market in November 2017. Moreover, the rising need for medical implantation due to the high prevalence of bone-dental disorders are driving the growth of the global 3D printed medical implants market.
On the other hand, the high cost of implants and stringent government regulations are likely to hamper the growth of the market.
Segmentation
The global 3D printed medical implants market has been segmented into component type, implantation technology, application, and end user.
By implantation technology, the market has been segmented into laser beam melting, electronic beam melting, droplet deposition, and others.
Based on application, the market has been segmented into dental, orthopedic, and cranio-maxillofacial.
The market, by end user, has been segmented into hospitals, medical device companies, research and academic institutes, and others.
Key Players
Some of the prominent players in the global 3D printed medical implants market are Materialise (Belgium), Renishaw plc (UK), 3D Systems, Inc. (US), Stratasys Ltd(Israel), ENVISIONTEC, INC. (US), Arcam AB (Sweden), SLM Solutions (Germany), Oxford Performance Materials (US), Bio3D Technologies (Singapore), Cyfuse Biomedical K.K. (Japan), TRUMPF (Germany), ADEISS (US), OsseoMatrix (US), AnatomikModeling (France), EIT Emerging Implant Technologies (Germany).
Table Of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Equipment Trends & Assessment
...
Hottest Trending Reports
Global Denture Adhesive Market Research Report - Forecast to 2021
Patient Registry Software Market Research Report - Global Forecast till 2023
Hair Transplant Market Research Report - Global Forecast till 2023
About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Wednesday 18 December 2019

Global Wound care Market Opportunities 2019-2027 | MRFR

Wound care Market Scenario:
Wound care products are used for the treatment or closure of wounds. The global wound care market is anticipated to generate at a CAGR of 6.2 % during the review period.
Market Dynamics:
Drivers
The ubiquitous applications of wound care coupled with the rising cases of trauma owing to growth in risk factors such as accidents, industrial hazards, sports culture, etc. are the prime drivers of the market. According to the American Burn Association estimates, approximately 486,000 burn injuries were reported in 2015. Advancements in wound care & closure products is resulting in increased substitution of traditional products owing to their effectiveness and efficacy.
Increased cases of diabetes and growing demand for cosmetic surgeries are other drivers of the market. There has been a strong demand for anti-scar products to treat complex wounds. Advanced materials include hydrogels, alginates, hydrocolloids, etc. which by providing moisture encourages natural cell repair. Hydrocolloid substances such as gelatin and cellulose, are being incorporated in products to absorb fluids, dirt, bacteria, and forming a protective gel mass without sticking to the wound itself.
Restraints
The high cost of advanced wound care products is the prime constraint on the market. Lack of awareness and low per capita income are other restraints on the market.
Wound care Market Segmentation:
To generate an advanced understanding of the global wound care market, the report is segmented on the basis of product, type, application, and end users.
Based on products, the market is segmented by traditional wound care products, advanced wound management products, wound care products, wound therapy devices, active wound care products, and others. The advanced wound management products segment is sub segmented into foam dressings, advanced wound dressings, collagen dressings, alginate dressings, hydrogel dressings, hydrocell foam dressings, others. The wound therapy devices segment is sub segmented into negative pressure wound therapy device (NPWT), electrical stimulation devices, oxygen and hyperbaric oxygen equipment, cutting edge wound therapy device, and others. The wound care products segment is sub segmented into sutures, surgical staples, wound care strips, haemostats, adhesives and tissue sealants, and others. The active wound care products segment is sub segmented into artificial skin and skin substitutes, topical agents, and others.
Based on the type, the market is categorized into chronic wounds, acute wounds, and others.
Based on the application, the market is segmented surgical wounds, ulcers, trauma wounds, burn, and others.
Based on the end users, the market is segmented into hospitals, clinics, trauma centers, home healthcare, and others.
Based on the regions, the market has been segmented by North America, Europe, Asia Pacific, Middle East and Africa.
Regional Analysis:
The Americas led by the U.S. dominate the global wound care market owing to a well-developed healthcare sector and high per capita income. The presence of global players like 3M and Baxter along-with the developed economies like the U.S and Canada within the region fuels the market growth.
Europe accounts for the second largest market for wound care. According to the National Health Service, the cost of caring for patients with chronic wounds in U.K. was estimated to be around USD 3.4 to 4.6 billion per year. Europe is led by Germany, France and the U.K.
Asia Pacific is the fastest growing region for the wound care market due to the presence of developing economies like India and China and large unmet needs. Indian healthcare sector is one of the fastest growing at an expected CAGR of 22.87 % during 2015 to 2020 and is anticipated to reach USD 280 billion by 2020. Favorable government policies like the National Health Insurance and growth in healthcare expenditure is expected to boost the market.
The Middle East & Africa is expected to generate a moderate growth due the presence of poor economies. The Gulf economies of Saudi Arabia, UAE, Kuwait, and Qatar dominate the Middle East and Africa region owing to well-developed healthcare sector and large healthcare expenditure.
Dominant players:
Some of the dominant players in the market are Ethicon, Inc. (U.S.), Braun Melsungen AG (Europe), Kinetic Concept, Inc. (U.S.), 3M (U.S.), Baxter (U.S.), Smith & Nephew (U.S.), ConvaTec (Europe), and others.
Posted by at No comments:
Labels: , ,

Friday 13 December 2019

Contact Lenses Market will register a CAGR of almost 5.7% by 2023

Market Synopsis:
Rising prevalence of eye disorders has led to an increase in demand for contact lenses, especially in the urban areas. A study conducted recently by Market Research Future has asserted that the Global Contact Lenses Market is expected to mark a CAGR of 5.70% across the projection period 2018 to 2023. The assessment further highlights that the global market’s valuation is anticipated to grow from USD 7.9 Billion in 2017 to USD 11 Bn by 2023.
Increasing disposable income has led to a shift in preferences to contact lenses over spectacles. This, in turn, is projected to proliferate the contact lenses market over the next couple of years. Also, technological innovations for offering more comfort to the users is expected to boost the expansion of the market in the years to come. However, on the flip side, some contact lenses can’t be wearing for a long period as it causes discomfort. This, in turn, is poised to undermine the proliferation of the contact lenses market in the forthcoming years.
Competitive Dashboard:
The key players participating in the global Contact lenses market profiled in this MRFR report for a detailed share analysis are Johnson & Johnson, CooperVision, Novartis, and Bausch+Lomb. Other market players studied in the report are Oculus Private Limited, Bescon Co. Ltd., St. Shine Optical Co. Ltd, Neovision Co. Ltd., Hoya Corporation, CAMAC Optical Corp., Seed Co. Ltd., Menicon Co. Ltd., and Clearlab SG PTE Ltd.
Market Segmentation:
By type, the global contact lenses market is segmented into therapeutic lenses, corrective lenses, and cosmetic & lifestyle oriented lenses. Among these, the corrective lenses segment is, at present, leading the growth of the market. It is anticipated to retain its prominent position over the next few years, reflecting a relatively higher CAGR of 5.22% during the assessment period. Factors such as the rising burden of eye disorders, rising geriatric population, increasing prevalence of geriatric eye diseases, etc. are expected to drive the expansion of the segment in the foreseeable future.
By material, the contact lenses market has been segmented into methacrylate hydrogel soft contact lens, gas-permeable contact lens, silicone hydrogel soft contact lens, and others. The silicone hydrogel soft contact lens segment is projected to account for over 60% of the market share by the end of the review period. The growth can be accredited to factors such as longer life span and high adoption for correcting astigmatism.
On the basis of design, the global contact lenses market has been segmented into toric lens, spherical lens, multi-focus lens, and others. Among these, the spherical lens segment is expected to account for more than 50% of the market share in the forthcoming years. The development of the segment is likely to be led by increasing cases of myopia and other refractive vision errors. In addition, the multifocal segment is prognosticated to expand at a comparatively higher CAGR across the projection period.
Regional Analysis:
The global contact lenses market, for a detailed geographical assessment, has been segmented into five major geographies - Europe, Asia Pacific, Latin America, North America, and the Middle East & Africa (MEA). Americas is leading the growth of the market currently and is anticipated to maintain its stand at the forefront position through the review period. Increasing demand for cosmetic lenses is a major factor expected to influence the expansion of the contact lenses market in the region in the upcoming years. In addition, the increasing burden of eye-related diseases is anticipated to expedite market growth over 2023. In the region., Meanwhile, Asia Pacific is poised to register the highest CAGR of 6.2% over the forecast period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312

Posted by at No comments:
Labels: , ,

Thursday 12 December 2019

Creatinine test Market : Latest Innovations, Drivers, Restraints, Challenges and Key Events in the industry by 2023

The global creatinine test market size is set to balloon till 2023 owing to rising incidence of chronic kidney disease (CKD) and technological advances witnessed in various diagnostic test kits. Market Research Future (MRFR)’s latest study reveals that the market is predicted to grow at a 5.8% CAGR during the forecast period (2018–2023). Government initiatives undertaken to create awareness of CKD among patients is expected to positively impact the market. Product launches by new and existing players to expedite the speed and accuracy of these tests can offer new growth opportunities for the market.


Increased emphasis on quality healthcare is anticipated to increase the healthcare budget of various nations, which in turn could bolster market demand for creatinine tests. According to a report by the National Center for Chronic Disease and Prevention, nearly 30 million U.S. residents were afflicted with CKD in 2017. This disease was more commonly seen in women more than men. Technologically advanced creatinine tests can help in lowering these numbers considerably. Advances in point-of-care diagnostics facilitated by automated analyzers, increasing diabetic populace, and presence of various public and private healthcare organizations providing support for CKD management can open up new avenues for the market.
Global Market for Creatinine Tests – Segmental Analysis
MRFR’s report offers a detailed segmental analysis of the market based on test type, product type, application, end-user, and region. By type, the market has been segmented into blood test, urine test, and creatinine clearance test. The blood test segment accounted for a large market share owing to preference of blood tests to measure creatinine levels in the Americas. It is expected to be lucrative for the market over the forecast period.
By product type, the market is segmented into consumables and instruments. Consumables are further segmented into cartridges, urine test strips, and others. Similarly, instruments are further segmented into clinical analyzers and others. Clinical analyzers are segmented into benchtop and handheld. The consumables segment is projected to register a 5.71% CAGR during the forecast period, as tools such as urine test strips can provide an accurate assessment of a patient’s urine level.
Major market applications include renal failure, kidney cancer, glomerulonephritis, urinary tract obstruction, and others. The urinary tract obstruction application segment is touted to capture a lion’s share of the creatinine test market by the end of the forecast period owing to the urinary tract being the most common area for blockage. The renal failure segment is expected to grow at a 6.26% CAGR over the forecast period.
End-users covered in the report include research institutes, diagnostic centers, hospitals & clinics, and others. The hospitals and clinics segment is expected to contribute to the market owing to rise in healthcare budgets of various nations.
Regional Outlook
The creatinine test market, on the basis of region, is segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas region accounted for a large share of the market in 2017. It will continue to dominate the market due to presence of sophisticated healthcare infrastructure, adoption of latest diagnostic tests, and incidence of CKD. Presence of various leaders of the healthcare industry coupled with a massive healthcare budget is expected to facilitate market growth. Favorable reimbursement policies can also influence patients in taking these tests to catch kidney related disorders at a preventive stage.
APAC and Europe collectively accounted for 51% market share. The APAC creatinine test market is driven by the large patient pool, rapidly improving healthcare infrastructure, and adoption of latest customer-centric healthcare models.
Global Market for Creatinine Test – Competitive Dashboard
Some of the key players profiled in the market report include Abbott, URIT Medical, Nova Biomedical, Siemens AG, ARKRAY, Inc., The Danaher Corporation, F. Hoffmann-La Roche AG, ACON Laboratories, Inc., Thermo Fisher Scientific, Inc., Quest Diagnostics, Abcam plc, OPTI Medical Systems, and others. Acquisitions, collaborations, and launch of new products are strategies employed by these players to acquire a larger market share. Approvals of new creatinine tests by respective regulatory agencies of various nations are expected to propel the market to new heights.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Autism Disorder and Treatment Market Size, Regional Outlook, Competitive Strategies and Forecasts to 2023

Autism Disorder and Treatment Market – Overview
The neurological and developmental effects of autism disorder are the core factors promoting the expansion of treatment and diagnostic options for autism. Market reports linked to the healthcare industry have been made available by Market Research Future which creates reports on other industry verticals that outlines the current market scenarios. The market is reportedly poised to achieve a CAGR of 4.37% approximately in the duration of the forecast period.
Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/1605
Autism Disorder and Treatment Market Segmentation
The global autism disorder and treatment market segmentation encompasses drugs, type, and treatment type. MRFR’s research on the market highlights many facets of the market in-depth.
Based on drugs, this market has been segmented into anti-convulsant drugs, anti-psychotic drugs, selective serotonin reuptake inhibitors (SSRIs), and stimulants. The antipsychotic drugs segment has been sub-segmented into Abilify (aripiprazole) and risperidone. The antipsychotic drugs segment has the maximum market coverage and is expected to grow at 3.95% CAGR during the forecast period.
By type, the market includes Asperger syndrome, pervasive developmental disorder, and others. During the forecast period, the pervasive developmental disorder is expected to grow at 4.73% CAGR, as it is the largest market segment.
Regarding treatment type, the market has been segmented into the applied behavioral analysis (ABA), chelation therapy, hyperbaric oxygen therapy, oxytocin therapy, and others. ABA is the largest and market segment, and during the forecast period, it is expected to grow at 4.82% CAGR.
Autism Disorder and Treatment Market Regional Segmentation
A geographical outlining of the global Autism Disorder and Treatment Market covers the Americas (North America & South America), Europe, APAC (Asia Pacific), and the Middle East & Africa (MEA).
The Americas region commands the maximum market share in the global market, followed by Europe. The presence of major market players, availability of advanced medical facilities, and technological advancement make North America a bigger market compared to South America. The market in North America is growing due to the approval, and it expects the launch of the atypical anti-psychotic such as Latuda and Namenda, with their high sales in the USA. Many autism cases have been detected in North America. After the USA, Canada generates maximum sales as well as revenue with regards to autism treatment and drugs.
Europe is the second-largest regional market as after North America; maximum major market players are based in Europe. The countries that can become important markets during the forecast period are France, Germany, Italy, Spain, and the UK. Research on the remaining countries in Western Europe featured in this report estimate the strong addition to market revenue from various other countries in this region, with some sizable market revenue from Eastern Europe.
During the forecast period, the market in the Asia Pacific region can be the fastest growing regional market. In this region, the factors contributing to the market growth include the expansion of diagnostic criteria, increasing prevalence of ASD, more awareness, better diagnostic tools, and improved reporting. The countries that can be crucial markets in this region are Australia, China, India, Japan, and South Korea.
During the forecast period, the market in the MEA region can grow steadily due to slow progress in the improvement of healthcare infrastructure. The countries that can be decent markets in this region are Kuwait, Oman, Saudi Arabia, Qatar, and the UAE.
Autism Disorder and Treatment Market Analyzed by Top Key Players
Big players in the global autism disorder and treatment market are Allergan (Ireland), Bristol-Myers Squibb (USA), Consern Pharma Private Limited (India), Coronis Partners Ltd. (Israel), Curemark LLC (USA), Eli Lilly & Company (USA), Heptares Therapeutics Limited (UK), Intra-Cellular Therapies Inc. (USA), Johnson & Johnson Services Inc. (USA), Merck & CO Inc. (USA), Novartis AG (Switzerland), Otsuka Holdings Co. Ltd. (Japan), Pfizer Inc. (USA), Saniona AB (Denmark), and Teva Pharmaceutical Industries Ltd. (Israel).
Latest Industry News
  • National Institute of Mental Health has awarded grant worth USD 3.3 Mn to Zylka Lab. The grant was approved based on a study and would be used for a better understanding of a genetic mutation in UBE3A that contributes to certain characteristics of autism. 18 SEP 2019
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)